Item Type | Name |
Academic Article
|
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.
|
Academic Article
|
A role for curative surgery in the treatment of selected patients with metastatic breast cancer.
|
Academic Article
|
Is extended hepatectomy for hepatobiliary malignancy justified?
|
Academic Article
|
Solitary colorectal liver metastasis: resection determines outcome.
|
Academic Article
|
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival.
|
Academic Article
|
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
|
Academic Article
|
Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
|
Academic Article
|
Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.
|
Academic Article
|
Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors.
|
Academic Article
|
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
|
Academic Article
|
Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.
|
Academic Article
|
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.
|
Academic Article
|
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases.
|
Concept
|
Survival Rate
|
Concept
|
Disease-Free Survival
|
Concept
|
Survival Analysis
|
Concept
|
Graft Survival
|
Academic Article
|
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
|
Academic Article
|
Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan.
|
Academic Article
|
Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.
|
Academic Article
|
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
|
Academic Article
|
Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
|
Academic Article
|
Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study.
|
Academic Article
|
Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.
|
Academic Article
|
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.
|
Academic Article
|
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.
|
Academic Article
|
Modified cisplatin/interferon a-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.
|
Academic Article
|
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis.
|
Academic Article
|
Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma.
|
Academic Article
|
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.
|
Academic Article
|
Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate.
|
Academic Article
|
Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
|
Academic Article
|
Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
|
Academic Article
|
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma.
|
Academic Article
|
RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
|
Academic Article
|
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
|
Academic Article
|
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.
|
Academic Article
|
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.
|
Academic Article
|
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
|
Academic Article
|
Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.
|
Academic Article
|
Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.
|
Academic Article
|
Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
|
Academic Article
|
Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer.
|
Academic Article
|
Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome.
|
Academic Article
|
Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?
|
Academic Article
|
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.
|
Academic Article
|
Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?
|
Academic Article
|
Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.
|
Academic Article
|
Outcome after curative resection for locally recurrent rectal cancer.
|
Academic Article
|
Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival.
|
Academic Article
|
Re: Right hepatic trisectionectomy for hepatobiliary disease: results and an appraisal of its current role.
|
Academic Article
|
Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.
|
Academic Article
|
Debunking dogma: surgery for four or more colorectal liver metastases is justified.
|
Academic Article
|
Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma.
|
Academic Article
|
Simplified staging for hepatocellular carcinoma.
|
Academic Article
|
Long-term survival after surgical management of neuroendocrine hepatic metastases.
|
Academic Article
|
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease.
|
Academic Article
|
Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease.
|
Academic Article
|
Preoperative predictors of survival after resection of small hepatocellular carcinomas.
|
Academic Article
|
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.
|
Academic Article
|
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation.
|
Academic Article
|
Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.
|
Academic Article
|
Morbidity and mortality in 1,174 patients undergoing hepatic parenchymal transection using a stapler device.
|
Academic Article
|
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer.
|
Academic Article
|
Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index.
|
Academic Article
|
Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.
|
Academic Article
|
Extrahepatic bile duct resection: standard treatment for advanced gallbladder cancer?
|
Academic Article
|
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
|
Academic Article
|
Colorectal liver metastases: treat effectively up front and consider the borderline resectable.
|
Academic Article
|
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
|
Academic Article
|
Treatment of unresectable hepatocellular carcinoma.
|
Academic Article
|
IHPBA concordant classification of primary liver cancer: working group report.
|
Academic Article
|
Primary and metastatic hepatic carcinoid: is there an algorithm?
|
Academic Article
|
Focus on treatment of large hepatocellular carcinoma.
|
Academic Article
|
Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
|
Academic Article
|
Surgical management of hilar cholangiocarcinoma.
|
Academic Article
|
Improved survival after resection of colorectal liver metastases.
|
Academic Article
|
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors.
|
Academic Article
|
Treatment of large and advanced hepatocellular carcinoma.
|
Academic Article
|
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
|
Academic Article
|
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
|
Academic Article
|
Blood loss in surgical oncology: neglected quality indicator?
|
Academic Article
|
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.
|
Academic Article
|
The management of solitary colorectal liver metastases.
|
Academic Article
|
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
|
Academic Article
|
Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.
|
Academic Article
|
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.
|
Academic Article
|
Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.
|
Academic Article
|
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.
|
Academic Article
|
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer.
|
Academic Article
|
Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease.
|
Academic Article
|
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
|
Academic Article
|
Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors.
|
Academic Article
|
Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome.
|
Academic Article
|
Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases.
|
Academic Article
|
Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.
|
Academic Article
|
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.
|
Academic Article
|
Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
|
Academic Article
|
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.
|
Academic Article
|
Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out.
|
Academic Article
|
Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center.
|
Academic Article
|
Management of colorectal liver metastases: past, present, and future.
|
Academic Article
|
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
|
Academic Article
|
Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver.
|
Academic Article
|
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
|
Academic Article
|
Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors.
|
Academic Article
|
Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases.
|
Academic Article
|
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.
|
Academic Article
|
Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.
|
Academic Article
|
Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.
|
Academic Article
|
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.
|
Academic Article
|
Colorectal metastases: resect or ablate?
|
Academic Article
|
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis.
|
Academic Article
|
The patient behind the code, the care behind the patient.
|
Academic Article
|
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy.
|
Academic Article
|
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.
|
Academic Article
|
Liver transplantation and hepatocellular carcinoma biology: beginning of the end of the era of educated guesses.
|
Academic Article
|
Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases.
|
Academic Article
|
Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
|
Academic Article
|
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
|
Academic Article
|
Steatosis as a risk factor in liver surgery.
|
Academic Article
|
Perioperative chemotherapy for resectable hepatic metastases.
|
Academic Article
|
Radiation treatment outcomes for unresectable hepatocellular carcinoma.
|
Academic Article
|
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.
|
Academic Article
|
Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.
|
Academic Article
|
RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.
|
Academic Article
|
Is complete liver resection without resection of synchronous lung metastases justified?
|
Academic Article
|
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.
|
Academic Article
|
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer.
|
Academic Article
|
Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival.
|
Academic Article
|
Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients.
|
Academic Article
|
RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.
|
Academic Article
|
Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms.
|
Academic Article
|
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy
|
Academic Article
|
Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases
|
Academic Article
|
RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases
|
Academic Article
|
Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status
|
Academic Article
|
Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival
|
Academic Article
|
Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma
|
Academic Article
|
Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients
|
Academic Article
|
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
|
Academic Article
|
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
|
Academic Article
|
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
|
Academic Article
|
Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases.
|
Academic Article
|
Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases.
|
Academic Article
|
RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
|
Academic Article
|
Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma.
|
Academic Article
|
Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma: a Novel Nomogram from the "HCC East & West Study Group".
|
Academic Article
|
Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.
|
Academic Article
|
Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery.
|
Academic Article
|
Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.
|
Academic Article
|
Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.
|
Academic Article
|
Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection.
|
Academic Article
|
Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.
|
Academic Article
|
Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy.
|
Academic Article
|
Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status.
|
Academic Article
|
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
|
Academic Article
|
Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
|
Academic Article
|
Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
|
Academic Article
|
Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma.
|
Academic Article
|
Long term outcome after resection of liver metastases from squamous cell carcinoma.
|
Academic Article
|
APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
|
Academic Article
|
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
|
Academic Article
|
Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries.
|
Academic Article
|
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.
|
Academic Article
|
Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.
|
Academic Article
|
Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival.
|
Academic Article
|
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
|
Academic Article
|
Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases.
|
Academic Article
|
Surgery: KRAS mutations and hepatic recurrence after treatment of colorectal liver metastases.
|
Academic Article
|
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.
|
Academic Article
|
Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases.
|
Academic Article
|
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma.
|
Academic Article
|
Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status.
|
Academic Article
|
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
|
Academic Article
|
Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
|
Academic Article
|
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.
|
Academic Article
|
Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
|
Academic Article
|
Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
|
Academic Article
|
Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.
|
Academic Article
|
Long-term survival after post-hepatectomy liver failure for colorectal liver metastases.
|
Academic Article
|
The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.
|
Academic Article
|
Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.
|
Academic Article
|
RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
|
Academic Article
|
R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
|
Academic Article
|
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.
|
Academic Article
|
The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.
|
Academic Article
|
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.
|
Academic Article
|
Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.
|
Academic Article
|
Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator.
|
Academic Article
|
Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.
|
Academic Article
|
Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.
|
Academic Article
|
Treatment Options for Metastatic Gastrointestinal Stromal Tumors to the Liver: A Review.
|
Academic Article
|
Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.
|
Academic Article
|
Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?
|
Academic Article
|
Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma".
|
Academic Article
|
Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation.
|
Academic Article
|
Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.
|
Academic Article
|
A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging.
|
Academic Article
|
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.
|
Academic Article
|
Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.
|
Academic Article
|
Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases".
|
Academic Article
|
Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.
|
Academic Article
|
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients.
|
Academic Article
|
Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO" Survival Benefit of ALPPS Versus TSH: A Proof of Concept or a Concept to be Proved?
|
Academic Article
|
A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status.
|
Academic Article
|
RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease.
|
Academic Article
|
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes.
|
Academic Article
|
Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis.
|
Academic Article
|
Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
|
Academic Article
|
Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer.
|
Academic Article
|
Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer.
|
Academic Article
|
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.
|
Academic Article
|
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma.
|
Academic Article
|
The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer.
|
Academic Article
|
AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing.
|
Academic Article
|
Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.
|
Academic Article
|
Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases.
|
Academic Article
|
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
|
Academic Article
|
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.
|
Academic Article
|
Colorectal Liver Micrometastases: Association with RAS/TP53 Co-Mutation and Prognosis after Surgery.
|
Academic Article
|
Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases.
|
Academic Article
|
Survival improvement for patients with metastatic colorectal cancer over twenty years.
|
Academic Article
|
Artificial Intelligence or Tumor Biology to Predict Survival After Resection of Colorectal Liver Metastases?
|
Academic Article
|
Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.
|
Academic Article
|
TP53 Alteration and Its Effect on Pathologic Response Are Associated with Survival after Resection of Colorectal Liver Metastases.
|
Academic Article
|
Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status.
|
Academic Article
|
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
|
Academic Article
|
Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases.
|